G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
Status:
Terminated
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving chemotherapy drugs and total-body irradiation before a donor bone marrow
transplant helps stop the growth of cancer and abnormal cells and helps stop the patient's
immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor
are infused into the patient they may help the patient's bone marrow make stem cells, red
blood cells, white blood cells, and platelets. Giving colony-stimulating factors, such as
G-CSF, to the donor helps the stem cells move from the bone marrow to the blood so they can
be collected and stored.
PURPOSE: This clinical trial is studying how well a G-CSF-treated donor bone marrow
transplant works in treating patients with hematologic cancer or noncancer.